AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank50
3Y CAGR+19.1%
5Y CAGR+0.8%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+19.1%/yr
vs -26.6%/yr prior
5Y CAGR
+0.8%/yr
Recent acceleration
Acceleration
+45.7pp
Accelerating
Percentile
P50
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
2 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 11.14% |
| 2024 | 4.79% |
| 2023 | -10.57% |
| 2022 | 6.60% |
| 2021 | 58.51% |
| 2020 | 10.71% |
| 2019 | 29.71% |
| 2018 | 22.80% |
| 2017 | 31.64% |
| 2016 | 18.33% |